CH5137291, an androgen receptor nuclear translocationinhibiting compound, inhibits the growth of castration-resistant prostate cancer cells.

MLA

Nobuyuki Ishikura, et al. “CH5137291, an Androgen Receptor Nuclear Translocationinhibiting Compound, Inhibits the Growth of Castration-Resistant Prostate Cancer Cells.” International Journal of Oncology, vol. 46, no. 4, Apr. 2015, pp. 1560–72. EBSCOhost, https://doi.org/10.3892/ijo.2015.2860.

APA

Nobuyuki Ishikura, Hiromitsu Kawata, Ayako Nishimoto, Ryo Nakamura, Toshiaki Tsunenari, Miho Watanabe, Kazutaka Tachibana, Takuya Shiraishi, Hitoshi Yoshino, Akie Honma, Takashi Emura, Masateru Ohta, Toshito Nakagawa, Takao Houjo, Corey, E., Vessella, R. L., Yuko Aoki, & Haruhiko Sato. (2015). CH5137291, an androgen receptor nuclear translocationinhibiting compound, inhibits the growth of castration-resistant prostate cancer cells. International Journal of Oncology, 46(4), 1560–1572. https://doi.org/10.3892/ijo.2015.2860

Chicago

Nobuyuki Ishikura, Hiromitsu Kawata, Ayako Nishimoto, Ryo Nakamura, Toshiaki Tsunenari, Miho Watanabe, Kazutaka Tachibana, et al. 2015. “CH5137291, an Androgen Receptor Nuclear Translocationinhibiting Compound, Inhibits the Growth of Castration-Resistant Prostate Cancer Cells.” International Journal of Oncology 46 (4): 1560–72. doi:10.3892/ijo.2015.2860.